logo

For the Inventor, By the Inventor

Tampa, FL, United States of America

Yin Xiong

This inventor holds 5 USPTO granted patents and 4 published patent applications. Top assignee: H. Lee Moffitt Cancer Center and Research Institute, Inc.. Active years: 2017-2023.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Yin Xiong. Retrieved from https://idiyas.com/inventor/yin-xiong

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 60.0

Average Co-Inventor Count = 3.0

ph-index = 1


Company Filing History:

goldMedal5 out of 312 
 
H. Lee Moffitt Cancer Center and Research Institute, Inc.
 patents

Years Active: 2017-2023

Loading Chart...
5 patents (USPTO):Explore Patents
1. 11643692 - Method of distinguishing lung squamous cell carcinoma from head and neck squamous cell carcinoma (2023-05-09),
2. 11618927 - Method of distinguishing urothelial carcinoma from lung and head and neck squamous cell carcinoma (2023-04-04),
3. 10982284 - Compositions and methods APC, CREB, and BAD pathways to assess and affect cancer (2021-04-20),
4. 9983209 - Method of diagnosing, treating and determining progression and survival of cancer cells using BCL-2 antagonist of cell death (BAD) pathway gene signature (2018-05-29),
5. 9809858 - O-glycan pathway ovarian cancer signature (2017-11-07),

Title: Innovations in Cancer Research by Inventor Yin Xiong

Introduction

Yin Xiong is a prominent inventor based in Tampa, FL (US), known for his significant contributions to cancer research. With a total of 5 patents, he has developed innovative methods that enhance the understanding and diagnosis of various types of cancer.

Latest Patents

Yin Xiong's latest patents include groundbreaking methods for distinguishing between different types of cancer. One notable patent is a method of distinguishing lung squamous cell carcinoma from head and neck squamous cell carcinoma, utilizing a 22-gene biomarker signature. Another important patent focuses on differentiating urothelial carcinoma from lung and head and neck squamous cell carcinoma, employing a 19-gene signature that can identify metastatic urothelial carcinoma in various contexts.

Career Highlights

Yin Xiong is affiliated with the H. Lee Moffitt Cancer Center and Research Institute, Inc., where he conducts his research. His work is pivotal in advancing cancer diagnostics and treatment strategies, contributing to improved patient outcomes.

Collaborations

Yin Xiong collaborates with esteemed colleagues, including Johnathan M Lancaster and Soner Altiok, enhancing the impact of his research through teamwork and shared expertise.

Conclusion

Yin Xiong's innovative approaches in cancer research exemplify the vital role of inventors in advancing medical science. His contributions are instrumental in the ongoing fight against cancer, showcasing the importance of research and innovation in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…